Less Ads, More Data, More Tools Register for FREE

Directorate Change

26 Jun 2020 07:00

RNS Number : 1515R
System1 Group PLC
26 June 2020

System1 Group PLC (AIM: SYS1)

("System1", or "the Company", or "the Group")

26 June 2020

Appointment of new executive director

System1 Group plc聽(AIM: SYS1) today announces that it has appointed Stefan Barden to the board of directors of the Company as an executive director with immediate effect. From November 2018, Stefan has been an adviser to the board of directors on strategy and technology, and has recently taken on the executive role of chief operating officer to assist the Company through its next phase of development. He will return to the advisory role when this is complete, expected to be in around a year.

Stefan has over 20 years of General Manager, Managing Director and CEO experience after graduating from McKinsey Management Consultancy and Unilever's fast track managment development programme. These include CEO of Northern Foods, CEO Heinz UK and Ireland, as well more latterly CEO of the internet business Wiggle which he took from 拢140m to 拢360m in sales in 3 years. Semi-retired, he also supports several CEOs, often founders, in developing high growth businesses. System1 is one of these companies.

Details in respect of Stefan Barden, as required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, are as set out below.

Additional Information

Stefan Barden, age 57, is currently or has been a director of the following companies within the past five years:

Current Directorships

Previous directorships

Victus Advisory Limited

Two11 Limited

Mapil Midco 1 Ltd

Mapil Midco 2 Ltd

Mapil TopCo Ltd

Wiggle Ltd

Mapil Bidco Limited

Ensco 503 Ltd

Decade Europe Ltd

Hotlines Europe Ltd

Chain Reaction Cycles Ltd

Chain Reaction Cycles Retail Ltd

Stefan Barden owns 716,062 ordinary shares in System1, representing 5.7% of the Company's voting share capital. In addition, on 18 April 2019 he received an equity award, comprising 300,000 zero cost stock options, which were approved at the Company's 2019 annual general meeting. They comprise three tranches of 100,000 options each, with the following performance conditions:

100,000 zero-priced stock options

Vest: when audited Gross Profit in any financial year exceeds 拢45m, subject to the Company's share price exceeding 拢5.00 per share for a 30 day consecutive period prior to the lapse date;

Lapse: on 30 July 2024.

100,000 zero-priced stock options

Vest: when audited Gross Profit in any financial year exceeds 拢68m, subject to the Company's share price exceeding 拢7.50 per share for a 30 day consecutive period prior to the lapse date;

Lapse: on 30 July 2029.

100,000 zero-priced stock options

Vest: when audited Gross Profit in any financial year exceeds 拢90m subject to share price exceeding 拢10.00 per share for a 30 day consecutive period prior to the lapse date;

Lapses: on 30 July 2032.

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

The Company can be found at聽www.system1group.com.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.聽Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAFELLLBQLZBBB

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS